Related Experiment Videos
Egr-1 target genes in human endothelial cells identified by microarray analysis.
Mingui Fu1, Xiaojun Zhu, Jifeng Zhang
1Department of Biochemistry, Cardiovascular Research Institute, Morehouse School of Medicine, 720 Westview Drive SW, MEB 1345, Research Wing, Room 215, Atlanta, GA 30310, USA.
Gene
|October 15, 2003
Summary
Early Growth Response Factor 1 (Egr-1) regulates over 300 genes in human endothelial cells, impacting vascular inflammation and apoptosis. This study identifies novel Egr-1 targets, advancing our understanding of its role in vascular health.
Area of Science:
- Molecular Biology
- Genomics
- Cardiovascular Research
Background:
- Early Growth Response Factor 1 (Egr-1) is a critical transcription factor involved in gene expression following vascular injury.
- Understanding Egr-1's function in the vasculature is crucial for developing therapeutic strategies.
Purpose of the Study:
- To comprehensively identify Egr-1 target genes in human endothelial cells.
- To elucidate the role of Egr-1 in regulating vascular cell function, including inflammation and apoptosis.
Main Methods:
- Adenoviral gene transfer was used to overexpress Egr-1 in human endothelial cells.
- Affymetrix oligonucleotide-based microarray technology was employed for global gene profiling.
- Northern and Western blotting were utilized for partial validation of identified target genes.
Main Results:
- Over 300 genes were identified as being regulated by Egr-1 with at least a 3-fold change.
- Key induced genes include thymus-expressed chemokine (TECK) and IP-30.
- Tumor Necrosis Factor alpha-Related Apoptosis-Inducing Ligand (TRAIL) expression was significantly repressed by Egr-1.
Conclusions:
- Egr-1 directly regulates a substantial number of genes in vascular endothelial cells.
- Egr-1 plays a significant role in mediating inflammation and apoptosis within vascular cells.
- The identified Egr-1 target genes provide new insights into vascular biology and disease.